PI3K/Akt/mTOR Signaling
PI3K/Akt/mTOR Signaling(PI3K/Akt/mTOR 信号传导)
PI3K/Akt/mTOR Signaling 相关产品(648)
- GC44642PI3-Kinase α Inhibitor 2 (hydrochloride)CAS: 1188890-32-5纯度: >98.00%
A PI3K p110α inhibitor
- GC45160Wortmannin-Rapamycin ConjugateCAS: 1067892-47-0纯度: >98.00%
Separate PI3K and mTORC1 inhibitors joined by prodrug linker
- GC46123Comprehensive Kinase Screening Library纯度: >98.00%
For screening of a variety of kinase inhibitors
- GC467387-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amineCAS: 1032570-74-3纯度: >95.00%
A building block
- GC47328Everolimus-d4CAS: 1338452-54-2纯度: >99.00%
An internal standard for the quantification of everolimus
- GC48012PtdIns-(4,5)-P2-fluorescein (triethylammonium salt)纯度: >95.00%
A neuropeptide with diverse biological activities
- GC48027Rapamycin-d3CAS: 392711-19-2纯度: >≥98% deuterated forms (d1-d3)
An internal standard for the quantification of rapamycin
- GC48507Kaempferol 3-O-galactosideCAS: 23627-87-4纯度: >98.00%
A flavonoid with diverse biological activities
- GC50009LY 294002 hydrochlorideCAS: 934389-88-5纯度: >98.00%
Prototypical PI 3-kinase inhibitor; also inhibits other kinases
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43790 | GSK3 Inhibitor XIII | 404828-08-6 | >98.00% | |
An inhibitor of GSK3 | ||||
| GC44475 | NVP-BEZ235 (hydrochloride) | 2319647-83-9 | >98.00% | |
Dual inhibitor of PI3K and mTOR | ||||
| GC44587 | PDMP (hydrochloride) | 73257-80-4 | >98.00% | |
An inhibitor of sphingolipid biosynthesis | ||||
| GC44641 | PI3-Kinase α Inhibitor 2 | 371943-05-4 | >98.00% | |
A PI3K p110α inhibitor | ||||
| GC44642 | PI3-Kinase α Inhibitor 2 (hydrochloride) | 1188890-32-5 | >98.00% | |
A PI3K p110α inhibitor | ||||
| GC44658 | PKI-179 (hydrochloride) | 1463510-35-1 | >98.00% | |
A dual PI3K and mTOR inhibitor | ||||
| GC44781 | PX-13-17OH | 884539-95-1 | >98.00% | |
A PI3K inhibitor | ||||
| GC44782 | PX-866-17OH | 1012327-63-7 | >98.00% | |
A PI3K inhibitor | ||||
| GC45160 | Wortmannin-Rapamycin Conjugate | 1067892-47-0 | >98.00% | |
Separate PI3K and mTORC1 inhibitors joined by prodrug linker | ||||
| GC46123 | Comprehensive Kinase Screening Library | - | >98.00% | |
For screening of a variety of kinase inhibitors | ||||
| GC46531 | 2-Amino-5-bromo-6-chloropyrazine | 173253-42-4 | >98.00% | |
A heterocyclic building block | ||||
| GC46724 | 6-Hydroxypyridin-3-ylboronic Acid | 903899-13-8 | >98.00% | |
A heterocyclic building block | ||||
| GC46738 | 7-Methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine | 1032570-74-3 | >95.00% | |
A building block | ||||
| GC47328 | Everolimus-d4 | 1338452-54-2 | >99.00% | |
An internal standard for the quantification of everolimus | ||||
| GC48012 | PtdIns-(4,5)-P2-fluorescein (triethylammonium salt) | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48027 | Rapamycin-d3 | 392711-19-2 | >≥98% deuterated forms (d1-d3) | |
An internal standard for the quantification of rapamycin | ||||
| GC48256 | VS-5584 analog | 1246535-95-4 | >98.00% | |
A dual inhibitor of PI3Kα and mTOR | ||||
| GC48507 | Kaempferol 3-O-galactoside | 23627-87-4 | >98.00% | |
A flavonoid with diverse biological activities | ||||
| GC48707 | MDK34597 | 371934-59-7 | >98.00% | |
A PI3K p110α inhibitor | ||||
| GC49392 | CHIR98024 | 556813-39-9 | >95.00% | |
A GSK3 inhibitor | ||||
| GC50009 | LY 294002 hydrochloride | 934389-88-5 | >98.00% | |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | ||||
| GC50072 | ETP 45658 | 1198357-79-7 | - | |
ETP 45658 是一种有效的 PI3K 抑制剂，对 PI3Kα、PI3Kδ、PI3Kβ 和 PI3Kγ 的 IC50 分别为 22.0 nM、39.8 nM、129.0 nM 和 717.3 nM。 ETP 45658 还可以抑制 DNA-PK (IC50\u003d70.6 nM) 和 mTOR (IC50\u003d152.0 nM)。 ETP 45658 可用于癌症研究。 | ||||
| GC50276 | LTURM 36 | 1879887-94-1 | - | |
PI 3-kinase δ inhibitor | ||||
| GC50332 | TC KHNS 11 | 1431540-99-6 | - | |
强效选择性 PI 3-激酶 δ；抑制剂；口服生物利用度 | ||||